Carbamic Acid

Carbamic Acid

SCHEMBL18813065

CCOc1ccc(-n2nnc3cnc(NC4CCCC4)nc32)cn1.NC(=O)O

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ MAPK6 Q16659 11/20 0.58
▸ GSK3A P49840 5/20 0.52
▸ GSK3B P49841 5/20 0.52
▸ EIF2AK4 Q9P2K8 2/20 0.42
▸ AURKA O14965 4/20 0.41
▸ CDK4 P11802 1/20 0.41
▸ CCND1 P24385 1/20 0.41
▸ CCND2 P30279 1/20 0.41
▸ CCND3 P30281 1/20 0.41
▸ CCNA2 P20248 1/20 0.39
▸ CDK2 P24941 1/20 0.39
▸ CCNA1 P78396 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18830111 0.94 MAPK6 (0.56) MAPK6GSK3AGSK3BEIF2AK4AURKA
Carbamic Acid SCHEMBL18813058 0.91 MAPK6 (0.65) MAPK6GSK3AGSK3BEIF2AK4AURKA
Carbamic Acid SCHEMBL18813021 0.89 MAPK6 (0.67) MAPK6GSK3AGSK3BEIF2AK4AURKA
SCHEMBL16011979 0.88 MAPK6 (0.66) MAPK6GSK3AGSK3BEIF2AK4AURKA
SCHEMBL18830110 0.88 MAPK6 (0.66) MAPK6GSK3AGSK3BEIF2AK4AURKA
Carbamic Acid SCHEMBL18813100 0.84 MAPK6 (0.57) MAPK6GSK3AGSK3BEIF2AK4
SCHEMBL18813047 0.84 MAPK6 (0.63) MAPK6GSK3AGSK3BEIF2AK4AURKA
SCHEMBL17435403 0.84 GSK3A (0.59) MAPK6GSK3AGSK3BEIF2AK4CDK2
SCHEMBL18830636 0.84 GSK3A (0.59) MAPK6GSK3AGSK3BEIF2AK4CDK2
SCHEMBL16012117 0.84 GSK3A (0.59) MAPK6GSK3AGSK3BEIF2AK4CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2964649-B1 TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER MERCK PATENT GMBH (DE) 2017-05-10 — — EP claimed
Send feedback